Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Imaging in MGUS, SMM and MM

NCT01237054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)

NCT04849416

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Wannan Medical College Yijishan Hospital Wuhu, Anhui, China
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 22 locations
View Trial Details
Completed

FASENRA Regulatory Postmarketing Surveillance in Korea

NCT05091333

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis), +21 more
Locations
  • Research Site Busan, South Korea
  • Research Site Gangneung-si, South Korea
  • Research Site Seoul, South Korea
  • Research Site Suwon, South Korea
View Trial Details
Completed

Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

NCT03275103

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital - Arizona Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
View all 17 locations
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)

NCT03598608

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0020) Gilbert, Arizona, United States
  • City of Hope ( Site 0001) Duarte, California, United States
  • Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) Los Angeles, California, United States
  • Pacific Cancer Care ( Site 0006) Monterey, California, United States
View all 25 locations
View Trial Details

Related conditions